key: cord-0791970-4v1s59i8 authors: Farmer, Natalie; Connor, Mary title: Reducing the risk of infection to patients and staff during gynaecological outpatient and ambulatory appointments date: 2021-03-18 journal: Best Pract Res Clin Obstet Gynaecol DOI: 10.1016/j.bpobgyn.2021.03.006 sha: a9fea752862c6d3d83a955625ebce62f157203cc doc_id: 791970 cord_uid: 4v1s59i8 This chapter explores ways of reducing the risk of SARS-CoV-2 transmission to women and staff within gynaecology outpatient clinics. The likely routes of transmission are discussed, namely via droplets, aerosols and fomites. Using the 'hierarchy of control' categories, elimination, substitution, engineering, administration and personal protective equipment (PPE), practical strategies for modifying virus exposure are presented. The management of specific clinical conditions are reviewed based upon advice prepared by the Specialist Societies in conjunction with each other and the Royal College of Obstetricians and Gynaecologists. The need to maintain at least a minimal level of gynaecological services is recognised and that this should provide safe, equitable and effective care. Ways of reducing clinic attendance are discussed with the substitution of face-to-face with remote consultations and when this is relevant. Current recommendations for ambulatory procedures, including colposcopy and hysteroscopy, are considered so that best use is made of reduced resources. The past months have seen the arrival of a wealth of new evidence in relation to transmission of SARS-CoV-2 and coronavirus disease 2019 . During this period, many hospitals in the UK have postponed all non-urgent care to ensure resources were made available to aid with the pandemic. However, this strategy is not feasible in the long-term and services need to resume as much as possible, whilst ensuring the safety of patients and staff. In order to minimise risk, virus transmission modes must be understood. A recent metaanalysis found that peak viral load levels are within the first five days of symptom development [1] , indicating that the height of infectiousness could be prior to clinical detection. Furthermore, those who are asymptomatic or with minimal symptoms may still have large viral loads [1] . All areas should therefore be treated as "COVID-19 minimised" as opposed to "COVID-19 free". Given the risk of asymptomatic patients carrying high viral loads of SARS-CoV-2, women attending gynaecology clinics should be treated as suspected carriers to minimise transmission risk. The primary mode of SARS-CoV-2 transmission, whether via respiratory droplets or aerosols, is debated.. Experimental data shows that SARS-CoV-2 could be transmitted via aerosols and that both droplets and aerosols are generated during speech, sneezing and coughing with a span of approximately 7 to 8m [2] . Although SARS-CoV-2 positive air samples do not equate to viable virus and higher infection risk, the evidence in support of airborne transmission is rising and this route should be considered in infection prevention strategies [3] . J o u r n a l P r e -p r o o f SARS-CoV-2 within droplets was found to remain viable for 72 hours on plastic and stainless steel and 84 hours on glass [3] , indicating the plausibility of fomite spread. Respiratory droplets appear to carry the highest risk of SARS-CoV-2 transmission, with other methods of transmission such as via aerosols or fomites being plausible but of unclear certainty. Transmission is more strongly associated with indoor spaces and prolonged close contact [4] . Preventing the spread of the virus should involve minimising risk via all potential transmission routes. Having established potential transmission routes of SARS-CoV-2, it is useful to consider how patients present to the gynaecology clinic and by following patient pathways identify ways of mitigating the risk of virus transfer. The 'hierarchy of control' provides a structured approach and in reducing order of effectiveness consists of, elimination, substitution, engineering, administration and personal protective equipment (PPE) [4]. 'Elimination' is regarded as the priority and here consists of limiting interactions between patients with each other and hospital staff in order to reduce nosocomial infection. Such actions include avoiding face-to-face encounters, fewer people attending at any one time when attendance is unavoidable, and minimising the duration of interactions. Triage of GP referrals to gynaecology into locally agreed categories allows the number of patients offered a face-to-face appointment to be reduced and controlled [5] . When J o u r n a l P r e -p r o o f insufficient information is available, a telephone consultation is likely to be useful and with the benefit of discussing possible investigations and treatment options directly with the patient [6] . Targeting patients with suspected gynaecological cancer symptoms is important to ensure that otherwise treatable cancers are not ignored, whilst ensuring vulnerable patients are not inappropriately exposed to infection. However, 'two-week wait' referral services should be maintained even if reduced [7] . Though some benign gynaecological conditions may require urgent attention, treatment of others may be safely deferred; clear pathways for assessment should be established [8]. Patients with a gynaecological condition who are not seen face-to-face still require care and attention. The Royal College of Obstetricians and Gynaecologists (RCOG) advise ensuring that a minimal level of service is available providing "safe, equitable, effective and quality care for all women" [5] . Telephone consultations can substitute for many face-to-face encounters [5] . Such a service could rapidly commence and would be accessible to most patients. Family members may be involved by using speakerphone facilities; where understanding and speaking of English is a factor, online interpreting services can be integrated into the consultation. Video consultations may aid in building rapport. Although randomised studies are small, the current evidence suggests that they are an effective consultation method with patients and staff reporting high satisfaction levels [9] . However, they are more complicated to set up, involve training and require the patient to have access to appropriate technology, which J o u r n a l P r e -p r o o f introduces a problem for some. Gynaecological services that favour remote consultations include fertility services and menopause clinics [10, 11]. The Japanese government adopted avoidance of the "three Cs: closed spaces with poor ventilation, crowded places with many people nearby and close-contact settings such as close-range conversations" [12] . Adequate ventilation can reduce indoor infections by dilution of SARS-CoV-2 aerosol particles [13] . Simple measures, such as opening windows, and encouraging natural ventilation, reduce transmission of other aerosol-transmitted diseases, including tuberculosis [14] . However, caution is necessary in gynaecology outpatients to balance the risks of preventing infection with thermal discomfort or potential loss of privacy. To reduce the risk of fomite transmission, surfaces, particularly those that are touched frequently, should be cleaned thoroughly and for one minute with 70-90% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite [15, 16] . Single-use cleaning equipment should be used where possible [17] and the "one wipe, one surface, one direction, dispose" policy adopted when wiping surfaces in order to prevent re-contamination [18] . Although there is insufficient evidence to support the frequency of cleaning different surfaces, interim guidance suggests at least twice daily for waiting areas, three times daily for shared toilets and after each patient visit for consultation rooms. A good overall standard of J o u r n a l P r e -p r o o f cleanliness is required, even in areas not frequently used [16] . Care should be taken to avoid splashes [17] . Ample provision of hand sanitiser for both staff and patient use is recommended. Alcoholbased hand rub with a minimum of 60% ethanol was found to inactivate viruses and should be applied for 20 to 30 seconds using a seven-step technique [19, 20] . Soap and water are another option for staff, with 15 seconds of handwashing leading to a 90% reduction of bacterial contamination and 30 seconds leading to 99% [21] . Following this, complete handdrying is essential to ensure there is no persistence of the virus. Paper towels surpass electric hand dryers in terms of hygiene and friction dislodges microorganisms from the hands [22] . Physical distancing is enabled with fewer people in the department with protection against contraction of SARS-CoV-2 roughly doubling for every additional metre of distance maintained, with two metres the recommended minimum distance. Appropriate PPE has been a pillar in the fight against COVID-19 and has provided healthcare staff with a high level of protection, but must comply with health and safety requirements outlined in Regulation (EU) 2016/425 [24] . N95 respirator masks are designed to protect a person from the surrounding environment, whereas surgical masks protect the environment from a person. Respirators generally provide more efficient protection when compared to surgical masks [25] . The standards for particulate respirators vary; disposable respirators must comply with EN 149:2001+A1:2009, whereas reusable respirators must comply with EN140:1998 and EN143:2000 [26] . There are disadvantages to N95 respirators; fit-testing is a vital part of ensuring an adequate seal to provide effectiveness. Furthermore, respirators often require more adjustment because of discomfort, with these adjustments leading to contamination [27] . In outpatient settings, both surgical masks and N95 respirators provide equivalent protection [28] . Surgical masks are sufficient unless aerosol-generating procedures are performed or when encountering a known infectious person. Patients attending the outpatient department are required to wear a face covering. Recent supply shortages resulted in the recommendation that surgical masks should be kept for healthcare professionals [29] . Homemade face coverings, typically made of cloth, vary in efficacy in preventing transmission, though any mask appears beneficial when compared with no mask at all [30] . Physiological exemptions include those with pre-existing respiratory conditions; however, they are at higher risk of severe COVID-19 and so for those with respiratory illness exemption from mask wearing is not recommended [31] . Psychological exemptions include those who are unable to tolerate or understand masks [32] . Gloves, gowns/aprons and eye protection also form vital components of effective PPE (see [26] . Long-sleeved gowns should be used when undertaking aerosolgenerating procedures or "when there is a risk of extensive splashing of blood and/or other body fluids", with an additional waterproof apron if the gown is not fluid-resistant [35] . A Cochrane review concluded with very low certainty that gowns may provide better protection J o u r n a l P r e -p r o o f than aprons [36] , however, this was only based on one study and further evidence is needed to guide recommendations. Eye protection includes safety glasses, goggles, face visors and panels that sit on top of facemasks and was found to reduce the transmission of coronaviruses in a meta-analysis [23]. Simulation studies have found both visors and goggles protect against other viruses when compared to no eye protection; however, they were not directly compared (see figure 3 ) [36] . Prescription eyeglasses provided no additional protection in a simulation model and were comparable to no eye protection at all [37] , however, many goggles fit over prescription eyeglasses. Goggles or face visors are the preferred and recommended form of eye protection [28] , but more research is required to determine their efficacy. Uncertainty exists around whether wearing both would be beneficial; at the present time, one form of eye protection is felt to be sufficient. The standard EN 166:2001 concerns all eye protection, which must comply with this standard prior to use in healthcare settings [26] . Gloves and gowns should be changed between patients. Facemasks worn to prevent the spread of one's own respiratory secretions (for example from talking or coughing) can be reused until soiled, damaged or hard to breathe through, but when used for protection from others' splashes and respiratory secretions should be changed between patients [38] . Eye protection may be cleaned with soap and water followed by disinfection with either sodium hypochlorite 0.1% or 70% alcohol wipes between uses [39] . Access to all required PPE should be provided in clinical settings. Training in donning and doffing minimises inadvertent contamination and should be provided. Double gloving may reduce contamination risks during this process but the benefits are unclear, and the certainty of evidence very low [36] ; again, further research is required to guide recommendations. Some gynaecological conditions can seriously damage health if treatment is deferred, with cancers an obvious example. However, even benign conditions can significantly harm health, therefore a minimal level of service is required at all times [5] . When referral for gynaecological services is considered, it is recommended that patient assessment through remote consultation is initially undertaken, with appropriate medical advice offered to minimise the need for women to visit their healthcare providers and reducing the risk of person-to-person viral transmission. Patients should be informed that for any face-to-face attendance they should wear a face covering unless exempt, and they should defer the appointment if they have suspected or confirmed COVID-19 infection, and self-isolate until no longer infectious. Principles for management of women with gynaecological disorders during the COVID-19 pandemic have been provided (see box 1) [5] . Taking these into account, the management of specific gynaecological disorders will be considered. << Insert box 1 here>> J o u r n a l P r e -p r o o f Concerns about performing ambulatory procedures in the outpatient clinic primarily focus on possible spread of the SARS-CoV-2 virus as a consequence of aerosol production or contamination by infected bodily fluids or smoke. Viral RNA has been identified in the lower genital tract, urine, faeces and blood, but with low prevalence; consequently the risk of virus dissemination from these body fluids appears to be minimal [41] . Therefore, gynaecological procedures should not pose a risk to healthcare workers. In view of the prevalence of asymptomatic carriers of SARS-CoV-2, the duration of many ambulatory procedures beyond 15 minutes, and the close proximity to the patient, as well as staff to each other, PPE worn by staff should include eye protection (goggles or visor), in addition to facemask, gloves and gown [34] . Consideration should be given to patients who become distressed during a procedure by inviting them to temporarily remove their face covering. When obtaining written consent, consider the pen used by a patient (see box 2). A framework for management of the diagnosis and treatment of women with a gynaecological cancer has been provided (see box 3) [6]. It acknowledges the compromise of cancer service facilities due to staff sickness and reduced treatment options in order to protect J o u r n a l P r e -p r o o f patients from nosocomial infection. The varied impact of the COVID-19 pandemic across the UK means that decisions about services will need to be made locally by gynaeoncology multidisciplinary teams (MDTs) [6]. Most women (>90%) referred to gynaecology fast track services do not have cancer despite having a 'red-flag' symptom or suspicious lesion [42] . Principles for safe and effective triaging of suspected cancer referrals is provided to ensure that priority is given to urgent referrals, with a safety net provided for downgraded referrals or when the standard investigations are deferred or not performed (see box 4) [43] . This should reduce clinic attendance and allow appropriate physical distancing between patients, particularly within waiting areas. Streaming patients directly to a test may also minimise interactions and appointments within health services [6]. << Insert box 4 here>> Support from primary care is required to ensure the appropriateness of the referral. When the clinical need is unclear, initial remote contact with patients may establish whether investigation can be safely deferred, or that a visit to the clinic is actually appropriate. Assessment of patients' vulnerability, especially for those who are shielding, enables as a suspected gynaecological cancer symptom [7] . The risk of endometrial cancer is lower in women on combined HRT than for women with PMB not taking HRT [45] . However, the J o u r n a l P r e -p r o o f symptom is often troublesome and causes anxiety and concern. The problem in the UK was compounded by limited availability of certain HRT preparations [11] , with consequent modifications to therapy resulting in new irregular vaginal bleeding. Nevertheless, women should be advised to seek advice if the blood loss continues beyond six months despite additional progestogen therapy (see box 6) [11] and especially if it fails to cease within six weeks of stopping HRT [46] . Assessment of the endometrium by TVS may be indicated, with an endometrial biopsy as appropriate. << Insert box 6 here>> C. 3 Similar concern arises about the association of endometrial cancer with intermenstrual bleeding (IMB); though it only warrants investigation in women with persistent loss for more than three consecutive months. Nevertheless, patients can be reassured that the risk of endometrial cancer is small and that symptoms often resolve spontaneously [47] . Many women can be managed remotely, and offered a trial without hormonal contraceptives for those using them, or a trial with hormonal contraceptives for those who are not. The risk of cancer increases with age and is reflected in the criteria for referral to secondary care (see Referral to secondary care to be seen within two weeks is indicated when: the appearance of the cervix is consistent with cervical cancer and the woman is aged <35 years with abnormal, absent or overdue smears, or is aged >35 years regardless of her smear history. A more relaxed timeframe of attendance within 42 days is appropriate when the woman has a satisfactory smear history and is aged <35 years [44] . Investigations should follow local protocols and testing resources, with consideration of endometrial investigation in postmenopausal women with PCB, particularly with a normal appearing cervix. Guidance is provided for the continuation of colposcopy services [48] . Advice should be offered remotely, following local guidelines by healthcare professionals with suitable expertise, for low-grade abnormalities, such as minor cytological changes and persistent HPV, in order to minimise attendance in clinics. As with any patient attending an outpatient clinic, women with suspected or confirmed COVID-19 disease should not attend, but their colposcopic examination deferred until they are no longer infectious. The exception to this is for women with significant symptoms indicating cervical cancer; in these circumstances staff must wear full PPE (see figure 2) during the consultation and examination. Cervical abnormalities may be excised electrosurgically using standard smoke extraction facilities because the smoke produced is unlikely to contain SARS-CoV-2 particles [41] . However, laser ablation and excision with vaporisation of tissue should not be used [48] . As with other clinical symptoms that may indicate cancer, when assessing an abdominal mass hospital attendances need minimising. Patients' symptoms can be established remotely and preferably within primary care, with attention particularly to women >50 years old with persistent abdominal symptoms, increased urinary urgency and/or frequency [7] . Standard guidance continues so women should be referred urgently if physical examination identifies ascites or an abdominal or pelvic mass that is not obviously fibroids [7] . Fibroids may be evident from previous scans, and the patient's knowledge about this may help avoid an inappropriate hospital visit. Given the current situation, an abdominal examination may not have taken place, however, assessing the Ca125 level remains pertinent. Local facilities vary but a drive-in, COVID-19secure phlebotomy service may be available. A "straight-to test" strategy is advocated, therefore symptomatic women with a substantially raised Ca125 level should be directed for an urgent computed tomography (CT) scan of the abdomen and pelvis rather than an initial ultrasound scan (USS), thus reducing the number of hospital visits [6]. The use of magnetic resonance imaging or USS assessment using the IOTA rules is advised when there is concern about a mass but with a low cancer risk [6] . The risk of malignancy index (RMI) can be calculated using the USS findings, and women in whom it is relatively low (<200) could be considered for virtual assessment and follow-up during the pandemic period [6]. Guidelines state consider referral "in women with an unexplained vulval lump, ulceration or bleeding" [7] . Despite only 1,300 new vulval cancers diagnosed annually in the UK [49] this is not reflected in the relatively high number of fast track referrals for vulval conditions [42] . With increased use of remote communication in primary and secondary care, photographic images may assist diagnosis, and images sent by patients can be forwarded securely. Given the low overall risk of malignancy, most vulval conditions may be managed symptomatically, with only referral of women who fail to respond to treatment. Little is known about how rare vaginal cancers present, but suspicious features include an unexplained palpable mass in or at the entrance to the vagina [7] . Unexplained, persistent vaginal bleeding should prompt a vaginal examination for a possible cancer; anecdotally, metastatic thyroid cancer or melanoma may present with a vaginal secondary. Guidance has been produced for managing women with abnormal uterine bleeding during the COVID-19 pandemic [44] . It is advised that women with heavy menstrual bleeding (HMB) are managed initially by remote communication, establishing the severity of symptoms, the likelihood of anaemia and the possible cause. Women may be reassured that the risk of malignancy is negligible [47] . For women with torrential bleeding or in whom severe anaemia is suspected emergency care may be required with appropriate treatment (see box 8). When anaemia is unlikely, oral medical treatments as opposed to a LNG-IUS are preferable [41] . Therefore, these services may continue during pandemic restrictions and enable women to undergo urgent investigations and treatments for uterine disorders. The range of services might need curtailing during times of greatest restriction, for example endometrial ablation for HMB replaced by medical treatments to reduce hospital attendances. However, there is a balance to be struck between, for example, a single visit for an outpatient endometrial ablation as opposed to multiple attendances for GnRHa injections. Whilst all women should be offered a choice of anaesthesia and treatment settings for hysteroscopic procedures, they should be advised that an outpatient setting avoids hospital admission, thereby minimising the risk of exposure to SARS-CoV-2. Infection control practices for hysteroscopic procedures in an outpatient setting include the use of PPE, complying with local and national protocols (see figure 2) . Also, best practices should be adopted as currently advised (see box 11) [41] . The continued need for menopause services is recognised [11] . Remote consultations are already a feature of some menopause services; expansion or introduction of these will ensure minimal face-to face encounters [11] . Women with new symptoms require access to information, advice and treatment, and those already receiving HRT need continued access to prescriptions; both groups will need to know the local pathways for obtaining medication. Reduced access to some HRT preparations has created difficulties in the UK for GPs and patients, but regular updates are provided about their availability [11] . The management of unscheduled bleeding on HRT is discussed above. Patients with chronic pelvic pain, sometimes as a consequence of endometriosis or adenomyosis, may be awaiting definitive surgical treatment but have found this to be postponed, seemingly indefinitely, by the COVID-19 pandemic. Treatment with oral progestogens, as for heavy menstrual bleeding (see Box 8), and non-steroidal medication may prove sufficient. However, episodic, cyclical or continuous severe pain not responding to these measures may be managed with GnRHa injections, with the addition of addback therapy (see box 10). Again, the use of 12-week duration therapy will reduce the number of clinical interactions. J o u r n a l P r e -p r o o f Patients attending urogynaecology clinics generally present with non-urgent conditions such as prolapse and/or urinary incontinence. A large proportion of these patients are aged >60 years making them more vulnerable should they contract COVID-19. Fortunately, there are few situations when an emergency admission to hospital is required. Guidance is available for the care of women with urogynaecological disorders. Patients who require a face-to-face consultation or review are identified, along with when they need to be seen [52] . Patients with urinary retention need urgent attention within 12 hours of presentation in order to prevent long-term bladder problems. Where the residual volume is over the normal range for the local hospital guidance, patients should be taught self-catheterisation and followed-up remotely to reduce the need for further hospital visits. The alternative is to insert an indwelling catheter and arrange a return visit for a trial without catheter (TWOC) at a convenient date. This is generally within seven days, but could be deferred. Occasionally, patients may develop a severe problem arising from a vaginal pessary, such as fistulation and this needs to be addressed within seven days, often for pessary removal. Such problems are usually secondary to either a Gelhorn or shelf pessary. Women with a vaginal pessary require regular follow-up. An initial telephone consultation may establish whether any problems indicating ulceration are present, such as vaginal J o u r n a l P r e -p r o o f bleeding or pain. If so, the women should be reviewed within 30 days. If vaginal bleeding is a concern and the uterus is present, then the patient would need assessment for PMB as above. Women with vaginal discharge or bleeding should be advised how to make contact and seek advice. Provided all remains well, the woman can be reassured that a delay of a few months for a pessary change will not cause harm. Routine vaginal ring pessary changes can be safely deferred for up to six months from when the change was due. However, this should be not be beyond three months for Shaatz, Gelhorn, shelf and double pessaries, otherwise the risk of ulceration and incarceration increases. A woman with new onset procidentia may require assessment within 30 days if she is experiencing bladder and bowel problems. However, if the problem is longstanding and causing minimal inconvenience this can be delayed. Most new referrals to urogynaecology clinics can be deferred until concerns about the COVID-19 pandemic are relaxed. For urinary incontinence, a virtual consultation will permit an assessment of the type of incontinence and for preliminary advice to be given, and this may enable commencement of initial treatment. Physical examination is essential for women with a prolapse in order to understand their condition and offer advice about management and treatment options, therefore a telephone consultation is of limited value and the appointment is best deferred. The advice regarding urogynaeclogical procedures is that they are non-urgent and therefore should be suspended for the duration of the COVID-19 pandemic [53] . This includes bladder instillations, Botox injections, percutaneous tibial nerve stimulation, insertion of urethral bulking agents and diagnostic cystoscopy for non-cancer-related symptoms. These procedures can be resumed with relaxation of pandemic restrictions. Fertility units throughout the UK closed during the first lockdown. However, with easing of pressures on the NHS, individual units reopened once their COVID-19 Treatment Commencement Strategy was approved [53] . During subsequent lockdowns it was felt safe for fertility units to continue [54] . Remote communication is effective for initial assessment of fertility patients with discussion about treatment options. Many fertility treatments and procedures are undertaken within an ambulatory setting; detailed guidance for recommencing these is available [54] . The importance of clear and effective communication with individuals seeking fertility treatment during the pandemic is emphasised [53] . A new consideration is the benefit of vaccination J o u r n a l P r e -p r o o f against SARS-CoV-2 before treatment is started, in order to avoid potential complications of COVID-19 during a subsequent pregnancy [53] . Outpatient hysteroscopy and colposcopy services may safely continue; it is advisable that these are undertaken by experienced clinicians to minimise the likelihood of complications J o u r n a l P r e -p r o o f requiring further healthcare interventions. Avoidance of inpatient episodes and the need for a general anaesthetic is advised. • SARS-CoV-2 transmission is probably primarily by droplet and aerosols; therefore, virus transmission is likely to be minimised by reducing patient attendance. • Attention to the clinic environment by ensuring adequate ventilation, maintaining high standards of cleanliness and ensuring staff wear appropriate personal protective equipment, will help reduce transmission between patients and staff. • Substitute face-to-face encounters with virtual consultations when examination or procedures are unlikely; use to establish level of vulnerability and assess whether deferring investigation is appropriate For women with acute, severe vaginal bleeding consider: • Oral tranexamic acid, 1g tds or qds (maximum 4 g/24 hours) • Oral high dose progestogens to rapidly suppress acute bleeding as single 21-day course, repeated cyclically days 5-26 monthly [51] , or continuously to induce amenorrhoea: SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 Transmission of SARS-CoV-2 and Mitigating Measures: EMG-SAGE 4th Framework for staffing of obstetrics and gynaecology units during the J o u r n a l P r e -p r o o f COVID-19 pandemic 2020 BGCS framework for care of patients with gynaecological cancer during the COVID-19 Pandemic Suspected cancer: recognition and referral RCOG. Restoration and Recovery: Priorities for Obstetrics and Gynaecology 2020 Video consultations in primary and specialist care during the covid-19 pandemic and beyond Evaluating the use of telemedicine in gynaecological practice: a systematic review Joint BMS/RCOG/RCGP/FSRH framework for restoration of menopause services in response to COVID Japanese citizens' behavioral changes and preparedness against COVID-19: An online survey during the early phase of the pandemic Environmental factors involved in SARS-CoV-2 transmission: effect and role of indoor environmental quality in the strategy for COVID-19 infection control Improving natural ventilation in hospital waiting and consulting rooms to reduce nosocomial tuberculosis transmission risk in a low resource setting Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents WHO. Cleaning and Disinfection of Environmental Surfaces: Interim Guidance 2020 European Centre for Disease Prevention and Control. Disinfection of environments in J o u r n a l P r e -p r o o f healthcare and non-healthcare settings potentially contaminated with SARS-CoV-2 2020 One Wipe, One Surface, One Direction, Dispose" as Best Practice in the Clinical Environment Anaesthesia and SARS Guidelines on Hand Hygiene in Health Care: A Summary First Global Patient Safety Challenge Clean Care is Safer Care Guideline for Hand Hygiene in Health-Care Settings The hygienic efficacy of different hand-drying methods: a review of the evidence Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis Regulation (EU) 2016/425 of the European Parliament and of the Council of 9 March 2016 on personal protective equipment and repealing Council Directive 89/686/EEC Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks? List of COVID-19 essential Protective Personal Equipment (PPE) 2020 Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis Facial protection for healthcare workers during pandemics: A scoping review How to Protect Yourself & Others 2021 The British Academy. Face masks and coverings for the general public: Behavioural knowledge, effectiveness of cloth coverings and public messaging 2020 Face masks, respiratory patients and COVID-19 Department of Health & Social Care. Face coverings: when to wear one, exemptions, and how to make your own 2020 Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review HSE Rapid Evidence Review PART ONE: Equivalence of N95 and FFP2 masks 2020 HSE Rapid Evidence Review PART TWO: Aprons, Gowns and eye protection 2020 Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff Eye Protection in Orthopaedic Surgery: An in Vitro Study of Various Forms of Eye Protection and Their Effectiveness Strategies for Optimizing the Supply of Facemasks Guidance on the use of respiratory and facial protection equipment Clinical guide for the management of cancer patients during the coronavirus pandemic 2020 Joint RCOG/BSGE Statement on gynaecological endoscopy during the COVID-19 pandemic 2020 Rapid-access gynecological in North London Letter: Cancer alliance information on managing cancer referrals 2020 BSGE and BGCS guidance for the management of abnormal uterine bleeding in the evolving Coronavirus (COVID-19) pandemic 2020 Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis Referral guidelines for suspected cancer: Clinical guideline Premenopausal abnormal uterine bleeding and risk of endometrial cancer Colposcopy guidance during COVID-19 pandemic 2020 Heavy menstrual bleeding: assessment and management Cyclical progestogens for heavy menstrual bleeding BSUG Guidance on management of Urogynaecological Conditions and Vaginal Pessary use during the Covid 19 Pandemic Human Fertilisation & Embryology Authority. FAQ Coronavirus (COVID-19) 2021 Human Fertilisation & Embryology Authority. Coronavirus (COVID-19) guidance for professionals 2021 CWH (GE_JCPO) Boxes and Figure Legends For delivery of safe, equitable, effective and quality gynaecological care, the minimum level of service requires: • Evidence-based, equitable, safe, compassionate and respectful care wherever, whenever and however it takes place • Protection and support of all staff with adherence to national guidance on infection prevention and control Box 2. When confirming patient consent: • Ask them to use their own pen • Otherwise, wipe the pen before and after use with antiviral solution Box 3. General principles for the management of gynaecological cancer during the Covid-19 Make decisions within gynaecological MDT frameworks and communicate clearly with patients • Deviations from normal standards of care may be appropriate depending upon what is safely • Minimise hospital face-to-face visits, consider remote communication for follow-up and/or patientinitiated consultations Box 4. Safe and effective triaging of cancer referrals • Continue not downgrading referrals without consulting the referring health professional • Prioritise particularly urgent referrals and introduce greater communication between primary and secondary care • For downgraded or avoided referrals, ensure safety-netting in case of patient deterioration or increased cancer risk • See within 30 days: women ≥40 years with persistent IMB (> 3 consecutive months • May see beyond 30 days: women <40 years, or women ≥40 years of age on hormonal contraceptives Modifying progestogen intake may control unscheduled bleeding: Continuous combined HRT regimens: • Increase progestogen e.g. utrogestan 100 mg daily to 200 mg daily • Add utrogestan, medroxyprogesterone acetate, or norethisterone when progestogen is within combined preparation or Mirena IUS Change to cyclical intake of progestogen if unscheduled bleeding continues Cyclical HRT regimens: • Increase progestogen dose: e.g. utrogestan from 200 mg to 300 mg for 12 days a month • Increase duration of progestogen e.g. from 14 to 21 days for a 28-day HRT cycle